ENDPOINTS NEWS14h
Bay­er says elin­zane­tant quelled hot flash­es in women un­der­go­ing can­cer treat­ment
As Bayer awaits an FDA decision on its non-hormonal treatment for hot flashes caused by menopause, it's unveiling new results ...
Monthly Prescribing Reference14h
Elinzanetant Reduces Hot Flashes Caused by Breast Cancer Therapy
Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.
Bayer hot flashes therapy for breast cancer patients hits main goal in late-stage trial
Bayer (BAYZF) (BAYRY) says elinzanetant, its experimental therapy for hot flashes, reached the main goals in a late-stage ...
Bayer menopause drug reduces hot flashes in breast cancer group
Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...
FierceBiotech22h
Bayer makes hot flash splash, hitting phase 3 breast cancer goal to steal march on Astellas
Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...